Checkpoint Therapeutics, Inc., clinical-stage immunotherapy and targeted oncology company, focuses on the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers. The company's lead antibody product candidate is Cosibelimab, a fully-human monoclonal antibody of IgG1 subtype that directly binds to programmed death ligand-1 (PD-L1) and blocks the PD-L1 interaction with the programmed death receptor-1 and B7.1 receptors; and CK-302, a human agonistic antibody that is designed to bind to and trigger signaling in GITR expressing cells. It is also developing Olafertinib, a third-generation epidermal growth factor receptor (EGFR) inhibitor, as a treatment for patients with EGFR mutation-positive non-small cell lung cancer; CK-103, a selective and potent small molecule inhibitor of bromodomain and extra-terminal bromodomains; and anti-carbonic anhydrase IX (CAIX) antibody, a fully human preclinical antibody to recognize CAIX expressing cells and kill them via antibody-dependent cellular cytotoxicity and complement-dependent cytotoxicity. The company has collaboration agreements with TG Therapeutics, Inc. to develop and commercialize certain assets in connection with its licenses in the field of hematological malignancies. The company was incorporated in 2014 and is based in Waltham, Massachusetts. Checkpoint Therapeutics, Inc. is a subsidiary of Fortress Biotech, Inc. The 2025 version of the report offers detailed insights into the company's strategies, developments, outlook and drivers. In addition to SWOT Analysis and Financial Overview, the report analyzes key projects, business description, products, services, brands, operating locations, subsidiaries and affiliates of Checkpoint Therapeutics Inc..
Checkpoint Therapeutics Inc. business operations across the value chain are included. Further, all major operating and planned locations, related contacts, details of subsidiaries and partnerships of Checkpoint Therapeutics Inc. are also analyzed.
Detailed SWOT Analysis of the company including key strengths and weaknesses of Checkpoint Therapeutics Inc. , on which it can build its business along with potential opportunities and threats in the near to medium term future are detailed.
Key employees of the company including the management team and board of directors are listed with their designations. Further, statistics on key parameters such as employee count, organization structure etc is provided.
Financial analysis of Checkpoint Therapeutics Inc. including key ratios, income statement, cash flow statement and balance sheet are provided for the company. In addition, Key historical events, summary analysis of Checkpoint Therapeutics Inc. and all latest updates of the company are provided.
The 2025 version of Checkpoint Therapeutics Inc. report is presented after intensive primary and secondary research processes and it presents the insights in a complete impartial and reader friendly format.
TABLE OF CONTENTS
1.1 List of Tables
1.2 List of Figures
2 Introduction to the Company
2.1 Checkpoint Therapeutics Inc.- Key Facts
2.2 Checkpoint Therapeutics Inc.- Geographic Locations
2.3 Checkpoint Therapeutics Inc.- Subsidiaries and Affiliates
2.4 Checkpoint Therapeutics Inc.- Business Divisions
2.5 Checkpoint Therapeutics Inc.- Key Employees
2.5.1 Management Team
2.5.2 Board of Directors
3. Checkpoint Therapeutics Inc. Strategic Analysis Review
3.1 Checkpoint Therapeutics Inc.- Key Strategies
3.2 Checkpoint Therapeutics Inc.- Company Outlook Statement
3.3 Checkpoint Therapeutics Inc.- SWOT Analysis
3.3.1 Checkpoint Therapeutics Inc.- Key Strengths
3.3.2 Checkpoint Therapeutics Inc.- Key Weaknesses
3.3.3 Checkpoint Therapeutics Inc.- Potential Opportunities
3.3.4 Checkpoint Therapeutics Inc.- Potential Threats
3.4 Checkpoint Therapeutics Inc.- Key Competitors
4. Business Description of the Company
4.1 Checkpoint Therapeutics Inc.- Business Overview
4.2 Checkpoint Therapeutics Inc.- Operations by Segment
5 Products and Services Details
5.1 Checkpoint Therapeutics Inc.- Key Products
5.2 Checkpoint Therapeutics Inc.- Key Service Areas
5.3 Checkpoint Therapeutics Inc.- Key Brands
6 Company Developments
6.1 Checkpoint Therapeutics Inc.- Company History
6.2 Checkpoint Therapeutics Inc.- Latest Developments
7 Financial Analysis
7.1 Checkpoint Therapeutics Inc.- Income Statements
7.2 Checkpoint Therapeutics Inc.- Balance Sheet
7.3 Checkpoint Therapeutics Inc.- Cash Flow Statements
8 Competitors and Industry Analysis
8.1 Checkpoint Therapeutics Inc.- Direct Competitors
8.2 Checkpoint Therapeutics Inc.- Competitor Financial Ratios comparison
8.3 Checkpoint Therapeutics Inc.- Competitor Stock Charts Comparison
8.4 Checkpoint Therapeutics Inc.- Industry Analysis
9 Appendix
9.1 About SWOTreports
9.2 Sources and Methodology
9.3 Contact Information
P.S.Financial Analysis will be provided only for companies reporting financial data.
Get Free Sample
At SWOT Reports, we understand the importance of informed decision-making in today's dynamic business landscape. To help you experience the depth and quality of our market research reports, we offer complimentary samples tailored to your specific needs.
Start Now! Please fill the form below for your free sample.
Why Request a Free Sample?
Evaluate Our Expertise: Our reports are crafted by industry experts and seasoned analysts. Requesting a sample allows you to assess the depth of research and the caliber of insights we provide.
Tailored to Your Needs: Let us know your industry, market segment, or specific topic of interest. Our free samples are customized to ensure relevance to your business objectives.
Witness Actionable Insights: See firsthand how our reports go beyond data, offering actionable insights and strategic recommendations that can drive your business forward.
Embark on your journey towards strategic decision-making by requesting a free sample from SWOT Reports. Experience the caliber of insights that can transform the way you approach your business challenges.
FAQ's
Gain valuable insights into the company for academic or business research purposes with this comprehensive profile. Key elements, such as SWOT analysis and corporate strategy, are included to support your research needs effectively.
Customer and Supplier Identification: Analyze the company’s business structure, operations, major products, services, and strategies to identify potential customers and suppliers.
Leverage a detailed SWOT analysis to understand and evaluate your competitors' business structures, strategies, and core performance metrics. This analysis offers an up-to-date and objective perspective on the company’s strengths, weaknesses, opportunities, and threats.
Didn’t find what you’re looking for? TALK TO OUR ANALYST TEAM
Need something within your budget? NO WORRIES! WE GOT YOU COVERED!
Reach Out to Us
Industries
Resources
Company
Sign up for Offers & Promotions
- Connect with us
- +91 630 95 25755
- sales@swotreports.com
-
Chat on WhatsApp
